Insulin Degludec 100 U/mL
insulin degludec · INJECTION, SOLUTION · Novo Nordisk Pharma, Inc.
No Recall HistoryCurrently in Shortage
Plain English
Insulin Degludec is a injection, solution containing insulin degludec at 100 U/mL, taken subcutaneous. Manufactured by Novo Nordisk Pharma, Inc..
Key Facts
- Brand Name
- Insulin Degludec
- Generic Name
- insulin degludec
- NDC Code (Product)
73070-400- Manufacturer
- Novo Nordisk Pharma, Inc.
- Strength
- 100 U/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA203314
- Drug Class
- Insulin Analog [EPC]
- Marketing Start
- 07/01/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is Insulin Degludec used for?
Insulin Degludec contains insulin degludec. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Insulin Degludec a controlled substance?
Insulin Degludec is not classified as a controlled substance by the DEA.
What is the generic name for Insulin Degludec?
The generic name for Insulin Degludec is insulin degludec. There are 7 other brand versions of insulin degludec.
What is the NDC code for Insulin Degludec 100 U/mL?
The NDC (National Drug Code) for Insulin Degludec 100 U/mL is 73070-400, listed by Novo Nordisk Pharma, Inc..